Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Filing of Definitive Proxy
Statement for Proposed Business Combination
Special meeting of Foresight Acquisition Corp. stockholders to approve the proposed
business combination to be held on November 18, 2021 at 9:00 a.m. Central Time.
New York, NY October 29, 2021
Foresight Acquisition Corp. (NASDAQ: FORE) (Foresight) and P3 Health Partners (P3), a patient centered and physician led population health management company, announced that on October 28, 2021, Foresight
filed a definitive proxy statement (the Proxy Statement) relating to the proposed business combination (the Business Combination) with P3. Foresight also announced that a special meeting of its stockholders will be held
at 9:00 a.m. Central Time on November 18, 2021, in connection with the Business Combination (the Special Meeting). The Proxy Statement is being mailed to Foresights stockholders of record as of the close of
business on October 8, 2021.
If the proposals at the Special Meeting are approved, the parties anticipate that the Business Combination will close
as promptly as practicable after the meeting, subject to the satisfaction or waiver (as applicable) of all other closing conditions.
Upon closing of the
Business Combination, the combined company will be named P3 Health Partners Inc. and will be listed on the NASDAQ under the new ticker symbol PIII.
We are excited to have reached this important milestone, said Sherif Abdou, CEO of P3. With our deep value-based care expertise and proven
track record for addressing some of the largest challenges in healthcare today, we look forward to successfully completing the proposed Business Combination and providing more high-quality care in order to improve patient outcomes and reduce medical
costs.
Greg Wasson, Chairman of Foresight, commented: The Foresight team is excited to be moving forward with this exceptional opportunity
and work closely with the P3 leadership team to combine our healthcare and public company experience with P3s deep expertise in value-based care.
About Foresight Acquisition Corp.
Foresight is a special
purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, visit
foresightacq.com.
About P3 Health Partners
P3 is a patient-centered and physician-led population health management company. Founded and led by physicians, P3 is a
team of doctors, clinicians and support service professionals with a shared passion for delivering value-based care. We leverage our deeply integrated and capital efficient care model, data and technology, physician leadership and community outreach
tools to create enhanced patient outcomes and experiences, greater satisfaction for providers and caregivers and lower care costs. For more information, visit p3hp.org.